Men’s health startup RxMen raises Rs 5 Cr in seed round led by IPV

RxMen, a Delhi-based men’s health tech startup, has raised Rs 5 crore (around $570K) in its seed round led by Inflection Point Ventures (IPV). The round also saw participation from SPA Family Ventures, Ankit Goel, Seven Square Ventures, along with a grant from Prosus Group.

The proceeds will be used for brand building, launching RxMen-branded products, and setting up co-branded clinics. The firm targets to achieve positive EBITDA by October 2025.

Founded in 2023 by Shailja Mittal, RxMen is a full-stack, clinic-led men’s health platform. It focuses on root-cause treatment across sexual health, hormones, skin, stress, and sleep.

Over the past 20 months, RxMen claims to have grown 100x in revenue and recently reported an MRR of $70,000 (Aug 2025), with an ARR projection of $1.7 million by FY26. It has already delivered over 30,000 consultations and is handling 6,000 consultations monthly through a network of 30 specialists in urology, psychiatry, sexology, and therapy.

RxMen has also developed a Sexual Health Index (SHI), now under validation at IIT Jodhpur, built from 25,000 anonymized consultations. It reports a 95% success rate based on SHI outcomes.

It will compete with Man Matters (Mosaic Wellness), Bold Care, and Traya.